Notably, the tumor-suppressive effect of CREPT depletion was comparable to that of CDK9 inhibition, suggesting that targeting CREPT could effectively recapitulate the tumor-suppressive effects of CDK9 inhibition. The gene discussed is CDK9; the disease is neoplasm.